https://ipm-a.com/ 2026-05-28T20:14:28+00:00 https://ipm-a.com/latest-news/ 2026-06-03T09:30:45+00:00 https://ipm-a.com/events/ 2026-05-29T12:16:43+00:00 https://ipm-a.com/about/governance/ 2026-05-28T07:12:40+00:00 https://ipm-a.com/cookie-policy/ 2026-05-27T10:45:47+00:00 https://ipm-a.com/playbook/ 2026-05-27T12:49:51+00:00 https://ipm-a.com/privacy-policy/ 2026-05-27T10:46:24+00:00 https://ipm-a.com/about/ 2026-05-27T09:41:45+00:00 https://ipm-a.com/activities/ 2026-05-28T19:54:14+00:00 https://ipm-a.com/disease-areas/ 2026-05-28T19:01:15+00:00 https://ipm-a.com/ipm-alliance-launches-at-the-world-health-assembly-in-geneva/ 2026-06-04T10:36:56+00:00 https://ipm-a.com/iapm-launches-oncology-pillar-at-asco-closing-the-gap-between-cancer-breakthroughs-and-patient-access/ 2026-06-03T09:24:12+00:00 https://ipm-a.com/wha-2026-who-resolution-moves-precision-medicine-onto-the-global-health-policy-agenda/ 2026-06-03T09:15:19+00:00 https://ipm-a.com/asco-2026-pancreatic-cancer-gets-its-precision-medicine-moment/ 2026-06-04T10:43:38+00:00 https://ipm-a.com/asco-2026-gi-cancers-are-finally-moving-out-of-oncologys-blind-spot/ 2026-06-04T10:44:15+00:00 https://ipm-a.com/asco-2026-ai-is-entering-cancer-care-before-the-rules-are-ready/ 2026-06-04T10:44:59+00:00 https://ipm-a.com/asco-2026-are-we-overtreating-cancer/ 2026-06-04T10:45:28+00:00 https://ipm-a.com/asco-2026-why-oncology-is-also-paying-attention-to-glp-1-medicines/ 2026-06-04T10:57:10+00:00 https://ipm-a.com/expert-profile/wenbin-li/ 2026-05-28T05:59:56+00:00 https://ipm-a.com/expert-profile/maria-p-neira/ 2026-05-28T05:58:03+00:00 https://ipm-a.com/expert-profile/vivek-subbiah/ 2026-05-27T22:16:26+00:00 https://ipm-a.com/expert-profile/malebona-precious-matsoso/ 2026-05-27T22:14:25+00:00 https://ipm-a.com/expert-profile/khalid-bin-jabor-al-thani/ 2026-05-27T21:50:19+00:00 https://ipm-a.com/expert-profile/elil-renganathan/ 2026-05-27T21:47:04+00:00 https://ipm-a.com/expert-profile/ruggero-de-maria/ 2026-05-27T21:35:54+00:00 https://ipm-a.com/expert-profile/manmeet-singh-ahluwalia/ 2026-05-27T21:34:19+00:00 https://ipm-a.com/expert-profile/marcel-tanner/ 2026-05-28T05:48:09+00:00 https://ipm-a.com/regulators-start-writing-the-rules-for-ai-driven-medicines/ 2026-06-04T11:01:02+00:00 https://ipm-a.com/ai-pathology-moves-from-demo-to-workflow/ 2026-06-04T11:04:47+00:00 https://ipm-a.com/fda-puts-ai-inside-the-evidence-machine/ 2026-06-04T11:06:41+00:00 https://ipm-a.com/alphagenome-makes-variant-interpretation-political/ 2026-06-04T11:39:16+00:00 https://ipm-a.com/ai-diagnosis-has-entered-the-access-debate/ 2026-06-04T11:44:19+00:00 https://ipm-a.com/the-amr-pipeline-is-too-thin-for-the-threat-ahead/ 2026-06-04T17:21:03+00:00 https://ipm-a.com/tb-diagnosis-moves-closer-to-the-patient/ 2026-06-04T11:51:25+00:00 https://ipm-a.com/hepatitis-elimination-is-still-losing-patients-before-diagnosis/ 2026-06-04T11:54:33+00:00 https://ipm-a.com/lenacapavir-turns-hiv-prevention-into-an-access-stress-test/ 2026-06-04T11:56:23+00:00 https://ipm-a.com/whos-amr-plan-turns-access-into-preparedness/ 2026-06-04T14:53:39+00:00 https://ipm-a.com/diabetic-eye-screening-is-becoming-risk-based/ 2026-06-04T14:55:37+00:00 https://ipm-a.com/abu-dhabi-puts-rare-eye-gene-therapy-on-the-regional-map/ 2026-06-04T14:58:23+00:00 https://ipm-a.com/ai-eye-screening-has-an-image-quality-problem/ 2026-06-04T14:59:55+00:00 https://ipm-a.com/ai-retinal-screening-moves-into-the-diabetes-clinic/ 2026-06-04T15:02:07+00:00 https://ipm-a.com/india-turns-ai-eye-screening-into-public-health-infrastructure/ 2026-06-04T15:03:21+00:00 https://ipm-a.com/geographic-atrophy-forces-europe-to-define-meaningful-vision-benefit/ 2026-06-04T15:04:49+00:00 https://ipm-a.com/eye-health-moves-from-charity-case-to-investment-case/ 2026-06-04T15:06:27+00:00 https://ipm-a.com/africas-cardiovascular-decade-is-a-system-design-problem/ 2026-06-04T15:07:30+00:00 https://ipm-a.com/inherited-lipid-screening-becomes-europes-prevention-test/ 2026-06-04T15:09:38+00:00 https://ipm-a.com/attr-gene-editing-restarts-but-safety-becomes-the-access-question/ 2026-06-04T15:12:39+00:00 https://ipm-a.com/routine-ct-scans-could-become-a-heart-failure-early-warning-system/ 2026-06-04T15:14:22+00:00 https://ipm-a.com/risk-prediction-cannot-simply-be-imported-from-europe/ 2026-06-04T15:25:03+00:00 https://ipm-a.com/personalised-cardiology-needs-a-digital-fabric-not-just-more-data/ 2026-06-04T15:26:08+00:00 https://ipm-a.com/ai-in-cardiology-moves-from-promise-to-policy-pressure/ 2026-06-04T15:28:35+00:00 https://ipm-a.com/europes-safe-hearts-plan-makes-prevention-a-political-test/ 2026-06-04T15:29:28+00:00 https://ipm-a.com/ai-diabetes-tools-need-infrastructure-before-scale/ 2026-06-04T15:31:27+00:00 https://ipm-a.com/diabetes-tech-moves-from-optional-add-on-to-earlier-care/ 2026-06-04T15:44:51+00:00 https://ipm-a.com/obesity-care-starts-moving-beyond-bmi/ 2026-06-04T15:46:48+00:00 https://ipm-a.com/canadas-generic-semaglutide-approval-tests-glp-1-affordability/ 2026-06-04T15:47:52+00:00 https://ipm-a.com/indias-obesity-campaign-dispute-tests-the-line-between-awareness-and-promotion/ 2026-06-04T15:48:36+00:00 https://ipm-a.com/englands-tirzepatide-rollout-shows-approval-is-not-access/ 2026-06-04T15:50:30+00:00 https://ipm-a.com/medicares-glp-1-bridge-turns-obesity-coverage-into-a-public-payer-experiment/ 2026-06-04T15:51:34+00:00 https://ipm-a.com/who-makes-obesity-treatment-a-global-access-test/ 2026-06-04T15:52:14+00:00 https://ipm-a.com/cyberbullying-becomes-a-youth-mental-health-policy-target/ 2026-06-04T15:53:26+00:00 https://ipm-a.com/alzheimers-agitation-gets-a-new-drug-but-care-pathways-still-lag/ 2026-06-04T15:54:16+00:00 https://ipm-a.com/rare-epilepsy-moves-toward-treating-the-cause/ 2026-06-04T15:55:36+00:00 https://ipm-a.com/huntington-gene-therapy-hits-the-evidence-wall/ 2026-06-04T15:56:44+00:00 https://ipm-a.com/rare-disease-policy-moves-into-the-individualised-therapy-era/ 2026-06-04T15:57:54+00:00 https://ipm-a.com/digital-mental-health-still-has-an-evidence-problem/ 2026-06-04T15:58:36+00:00 https://ipm-a.com/alzheimers-access-now-starts-with-genotyping-and-mri-capacity/ 2026-06-04T15:59:37+00:00 https://ipm-a.com/europes-mental-health-projects-move-from-crisis-talk-to-delivery-tools/ 2026-06-04T16:00:22+00:00 https://ipm-a.com/europes-epilepsy-rules-start-catching-up-with-precision-treatment/ 2026-06-04T16:01:21+00:00 https://ipm-a.com/sma-screening-shows-precision-neurology-starts-before-symptoms/ 2026-06-04T16:03:00+00:00 https://ipm-a.com/post-stroke-cognitive-screening-needs-local-tools/ 2026-06-04T16:03:50+00:00 https://ipm-a.com/europes-stroke-plan-turns-speed-into-a-policy-test/ 2026-06-04T16:05:30+00:00 https://ipm-a.com/parkinsons-research-moves-from-tracking-progression-to-defining-biology/ 2026-06-04T16:06:17+00:00 https://ipm-a.com/ms-monitoring-starts-moving-beyond-the-mri-bottleneck/ 2026-06-04T16:07:21+00:00 https://ipm-a.com/latin-america-challenges-the-dementia-biomarker-evidence-gap/ 2026-06-04T16:08:20+00:00 https://ipm-a.com/chinas-alzheimers-blood-test-rollout-turns-diagnosis-into-an-access-market/ 2026-06-04T16:09:02+00:00 https://ipm-a.com/alzheimers-blood-testing-moves-toward-routine-care/ 2026-06-04T16:09:54+00:00 https://ipm-a.com/ai-mental-health-support-becomes-a-governance-test/ 2026-06-04T16:11:31+00:00 https://ipm-a.com/alzheimers-drugs-force-nice-back-into-the-value-debate/ 2026-06-04T16:12:17+00:00 https://ipm-a.com/europe-starts-treating-brain-health-as-system-resilience/ 2026-06-04T16:13:43+00:00 https://ipm-a.com/oncology-trials-still-do-not-match-the-patients-they-will-treat/ 2026-06-04T16:27:21+00:00 https://ipm-a.com/cancer-pharmacogenomics-exposes-an-ancestry-gap-in-routine-testing/ 2026-06-04T16:27:55+00:00 https://ipm-a.com/biomarker-testing-is-rising-but-eligibility-still-gets-lost/ 2026-06-04T16:28:37+00:00 https://ipm-a.com/colon-cancer-mrd-testing-is-nearing-the-access-threshold/ 2026-06-04T16:29:20+00:00 https://ipm-a.com/breast-cancer-blood-tests-could-bring-treatment-decisions-earlier/ 2026-06-04T16:30:24+00:00 https://ipm-a.com/lung-cancer-screening-now-has-a-diagnostic-bottleneck/ 2026-06-04T16:31:05+00:00 https://ipm-a.com/liquid-biopsy-turns-precision-oncology-into-an-nhs-delivery-test/ 2026-06-04T16:31:51+00:00 https://ipm-a.com/molecular-testing-is-europes-real-precision-oncology-infrastructure/ 2026-06-04T16:32:42+00:00 https://ipm-a.com/cancer-approval-is-no-longer-enough/ 2026-06-04T16:33:52+00:00 https://ipm-a.com/europes-cancer-inequality-map-becomes-a-performance-test/ 2026-06-04T16:34:26+00:00 https://ipm-a.com/europes-cancer-projects-start-looking-like-delivery-infrastructure/ 2026-06-04T16:35:02+00:00 https://ipm-a.com/eu-cancer-policy-moves-back-into-budget-politics/ 2026-06-04T16:35:35+00:00 https://ipm-a.com/genomic-matching-works-when-the-evidence-is-strong-enough-to-act/ 2026-06-04T16:36:09+00:00 https://ipm-a.com/precision-oncology-is-moving-faster-than-europes-access-machinery/ 2026-06-04T16:36:46+00:00 https://ipm-a.com/englands-cancer-plan-turns-personalised-care-into-a-national-delivery-test/ 2026-06-04T16:37:27+00:00 https://ipm-a.com/cancer-drugs-put-europes-new-hta-system-to-its-first-real-test/ 2026-06-04T16:37:57+00:00